Recent studies showed that celecoxib inhibited angiogenesis, tumor growth and metastasis in pancreatic xenograft tumors (28,29), and celecoxib also inhibited pancreas cancer formation in a COX-2 overexpressing mouse (30). Here, PTGS2 is linked to pancreatic neoplasm.